Borkar Roshan M, Raju B, Srinivas R, Patel Prashant, Shetty Satheesh Kumar
National Centre for Mass Spectrometry, Indian Institute of Chemical Technology, Hyderabad, 500 607, India.
Biomed Chromatogr. 2012 Jun;26(6):720-36. doi: 10.1002/bmc.1721. Epub 2011 Oct 12.
A rapid, specific and reliable isocratic high-performance liquid chromatography combined with quadrupole time-of-flight electrospray ionization tandem mass spectrometry (LC/Q-TOF-ESI-MS/MS) method has been developed and validated for the identification and characterization of stressed degradation products of metoprolol. Metoprolol, an anti-hypertensive drug, was subjected to hydrolysis (acidic, alkaline and neutral), oxidation, photolysis and thermal stress, as per ICH-specified conditions. The drug showed extensive degradation under oxidative and hydrolysis (acid and base) stress conditions. However, it was stable to thermal, neutral and photolysis stress conditions. A total of 14 degradation products were observed and the chromatographic separation of the drug and its degradation products was achieved on a C(18) column (4.6 × 250 mm, 5 µm). To characterize degradation products, initially the mass spectral fragmentation pathway of the drug was established with the help of MS/MS, MS(n) and accurate mass measurements. Similarly, fragmentation pattern and accurate masses of the degradation products were established by subjecting them to LC-MS/QTOF analysis. Structure elucidation of degradation products was achieved by comparing their fragmentation pattern with that of the drug. The degradation products DP(2) (m/z 153) and DP(14) (m/z 236) were matched with impurity B, listed in European Pharmacopoeia and British Pharmacopoeia, and impurity I, respectively. The LC-MS method was validated with respect to specificity, linearity, accuracy and precision.
已开发并验证了一种快速、特异且可靠的等度高效液相色谱结合四极杆飞行时间电喷雾电离串联质谱(LC/Q-TOF-ESI-MS/MS)方法,用于鉴定和表征美托洛尔的强制降解产物。美托洛尔是一种抗高血压药物,按照国际协调会议(ICH)规定的条件,对其进行了水解(酸性、碱性和中性)、氧化、光解和热应激实验。该药物在氧化和水解(酸和碱)应激条件下显示出广泛降解。然而,它对热、中性和光解应激条件稳定。共观察到14种降解产物,在C(18)柱(4.6×250 mm,5 µm)上实现了该药物及其降解产物的色谱分离。为了表征降解产物,首先借助MS/MS、MS(n)和精确质量测量确定了该药物的质谱裂解途径。同样,通过对降解产物进行LC-MS/QTOF分析,确定了它们的裂解模式和精确质量。通过将降解产物的裂解模式与该药物的裂解模式进行比较,实现了降解产物的结构解析。降解产物DP(2)(m/z 153)和DP(14)(m/z 236)分别与欧洲药典和英国药典中列出的杂质B和杂质I匹配。对LC-MS方法的特异性、线性、准确性和精密度进行了验证。